Number of hits necessary for complement-mediated hemolysis. 1986

J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue

The number of hits necessary for the C8 and C9 steps of immune hemolysis was reexamined with a previously unemployed experimental design, in which various numbers of EAC1-7, excess of the supplementary component and a constant amount of the component tested were incubated in a constant volume (Inoue et al. 1976. Infect. Immun. 13: 337). Our results were consistent with previous findings; the steps of guinea pig C8 and C9, the human C8 each followed a one-hit mechanism, while that of human C9 showed ka multi-hit response. When lysis of sensitized erythrocytes (EA) by normal human serum was analysed in a similar way, one-hit curves were obtained. This result, taken together with the above results, suggests that immune hemolysis occurs by a single lesion including a single C8 and multiple C9 in the case of human complement and that normal human serum contains sufficient excess of C9. On the other hand, when C9-deficient human serum was used for lysis of EA, multiple-hit curves were obtained. The mechanism of lysis by C5b-8 may differ from that by C5b-9.

UI MeSH Term Description Entries
D007122 Immunoelectrophoresis A technique that combines protein electrophoresis and double immunodiffusion. In this procedure proteins are first separated by gel electrophoresis (usually agarose), then made visible by immunodiffusion of specific antibodies. A distinct elliptical precipitin arc results for each protein detectable by the antisera.
D003185 Complement C8 A 150-kDa serum glycoprotein composed of three subunits with each encoded by a different gene (C8A; C8B; and C8G). This heterotrimer contains a disulfide-linked C8alpha-C8gamma heterodimer and a noncovalently associated C8beta chain. C8 is the next component to bind the C5-7 complex forming C5b-8 that binds COMPLEMENT C9 and acts as a catalyst in the polymerization of C9. C8 Complement,Complement 8,Complement Component 8,Complement Component C8 alpha,Complement Component C8 alpha Chain,Complement Component C8 beta,Complement Component C8 beta Chain,Complement Component C8 gamma,Complement Component C8 gamma Chain,C8, Complement,Complement, C8,Component 8, Complement
D003186 Complement C9 A 63-kDa serum glycoprotein encoded by gene C9. Monomeric C9 (mC9) binds the C5b-8 complex to form C5b-9 which catalyzes the polymerization of C9 forming C5b-p9 (MEMBRANE ATTACK COMPLEX) and transmembrane channels leading to lysis of the target cell. Patients with C9 deficiency suffer from recurrent bacterial infections. C9 Complement,Complement 9,Complement Component 9,C9, Complement,Complement, C9,Component 9, Complement
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
March 1966, Journal of immunology (Baltimore, Md. : 1950),
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
June 2004, Drug news & perspectives,
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
November 2001, The Journal of biological chemistry,
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
January 1975, International archives of allergy and applied immunology,
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
January 2018, Journal of veterinary internal medicine,
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
December 1999, Biochimica et biophysica acta,
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
November 1986, Biulleten' eksperimental'noi biologii i meditsiny,
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
November 2015, Haematologica,
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
September 2018, Journal of molecular medicine (Berlin, Germany),
J Takeda, and H Kozono, and Y Takata, and K Hong, and T Kinoshita, and K Sayama, and E Tanaka, and K Inoue
February 1984, Acta pathologica, microbiologica, et immunologica Scandinavica. Section C, Immunology,
Copied contents to your clipboard!